Plus Therapeutics (PSTV) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

PSTV is expected to report earnings to fall 12.50% to -12 cents per share on August 16

Plus Therapeutics PSTV Stock Earnings Reports

Q2'23

Est.

$-0.12

Q1'23

Est.

$-0.14

Q4'22

Missed

by $0.62

Q3'22

Beat

by $0.01

Q2'22

Missed

by $0.02

The last earnings report on April 20 showed earnings per share of -14 cents, meeting the estimate of -14 cents. With 43.70K shares outstanding, the current market capitalization sits at 6.31M.

View a ticker or compare two or three

Compare

PSTV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PSTV
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

4200 Marathon Boulevard

Phone

+1 737 255-7194

Employees

Web

https://www.plustherapeutics.com